Qube Research & Technologies (QRT)
ATXS

Qube Research & Technologies (QRT)’s Astria Therapeutics ATXS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,057,230
Closed -$13.8M – 3526
2025
Q4 		$13.8M Buy
+1,057,230
New +$12.6M 0.01% 1129
2024
Q4 		– Sell
-29,414
Closed -$324K – 3445
2024
Q3 		$324K Sell
29,414
-90,255
-75% -$1M ﹤0.01% 2404
2024
Q2 		$1.09M Buy
+119,669
New +$1.17M ﹤0.01% 1849
2023
Q2 		– Sell
-34,068
Closed -$453K – 2382
2023
Q1 		$453K Buy
34,068
+21,517
+171% +$291K ﹤0.01% 1599
2022
Q4 		$187K Buy
+12,551
New +$129K ﹤0.01% 1843

Qube Research & Technologies (QRT)'s ATXS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 1,057,230 shares — an estimated $13.8M sold.

Qube Research & Technologies (QRT) first reported a position in ATXS in Q4 2022 and held it in 5 quarters. The position peaked at $13.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,057,230 Astria Therapeutics shares in Q1 2026, an estimated $13.8M.
  • Qube Research & Technologies (QRT) first reported a position in Astria Therapeutics in Q4 2022 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Astria Therapeutics position peaked at $13.8M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.